Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03935295
PHASE4

Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis

Sponsor: Johns Hopkins University

View on ClinicalTrials.gov

Summary

This study evaluates the combined effect of botulinum toxin A (administered as Dysport® (Ipsen Pharmaceuticals)) and bracing in children with adolescent idiopathic scoliosis. Two thirds of patients will be treated with Dysport® and bracing, while the remaining patients will be treated with placebo and bracing.

Official title: Dysport ® (abobotulinumtoxinA) as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis

Key Details

Gender

All

Age Range

10 Years - 16 Years

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2020-09-03

Completion Date

2026-12-31

Last Updated

2025-12-09

Healthy Volunteers

No

Interventions

DRUG

AbobotulinumtoxinA

Paraspinal abobotulinumtoxinA injections (compared to placebo)

DRUG

Placebos

Placebo prepared by Ipsen for use as control

DEVICE

Custom Thoracolumbosacral Orthosis

Non-operative external bracing for scoliosis curves

Locations (1)

Johns Hopkins University

Baltimore, Maryland, United States